Ability of sextant biopsies to predict radical prostatectomy stage (Q40857051)

24 September 2017

title

Ability of sextant biopsies to predict radical prostatectomy stage (English)

1 reference

24 September 2017

Wills ML

1 reference

24 September 2017

Sauvageot J

1 reference

24 September 2017

Partin AW

1 reference

24 September 2017

Gurganus R

1 reference

24 September 2017

Epstein JI

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

1 reference

inferred from page(s)

published in

Urology

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

759-764

1 reference

Identification of insignificant prostate cancers: analysis of preoperative parameters

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Morphometric and Clinical Studies on 68 Consecutive Radical Prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Making the most out of six systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Clinical significance of repeat sextant biopsies in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900011-9

7 January 2021

10.1016/S0090-4295(98)00011-9

Identifiers

DOI

1 reference

24 September 2017

1 reference